Search
for
Sort by
Research 151–180 of 284
- Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism
- Vitiligo and alopecia areata: apples and oranges?
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Pathomechanisms of immune-mediated alopecia
- Alopecia Universalis Successfully Treated With Adalimumab
- A transcriptomic map of murine and human alopecia areata
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Association Between Interleukin 18 Polymorphisms and Alopecia Areata in Koreans
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
- Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions
- Cell death in skin function, inflammation, and disease
- Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Metabolic syndrome and dermatological diseases: association and treatment
- The association between rs2476601 polymorphism in PTPN22 gene and risk of alopecia areata
- Genetically predicted levels of circulating cytokines and the risk of six immune skin diseases: a two-sample Mendelian randomization study
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- Alopecia universalis unter Adalimumabtherapie bei einer Patientin mit rheumatoider Arthritis
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives